Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (AdvSM): Results from Part 1 of the Phase 2 Apex Trial

Pankit Vachhani, Tsewang Tashi, Gary J. Schiller, Stephanie Lee, Miguel Piris Villaespesa, Helena Pomares, Cristina Bulai Livideanu, Jonathan Lambert, Anthony M. Hunter, Tracy I. George, Cristina Papayannidis, Khalid Shoumariyeh, Rita Petroro, Jenna Zhang, Amanda Pilla, Hina Jolin, Rachael Easton, Vinod Pullarkat

Blood (2023) 142 (Supplement 1): 4567.

https://doi.org/10.1182/blood-2023-178885

Published: 2023

Journal Articles

Utilization of Natural Language Processing in Venous Thromboembolism Identification

Jonathan Avery, Kylee L Martens, Daniel Nguyen, Ryan Basom, Stephanie Lee, David A. Garcia, Cristhiam Mauricio Rojas Hernandez, Ang Li

Blood (2022) 140 (Supplement 1): 7860–7861.

https://doi.org/10.1182/blood-2022-165426

Published: 2022

Journal Articles

Patient-Reported Outcomes (PROs) Among Patients With Steroid-Refractory or -Dependent Chronic Graft-vs-Host Disease (cGVHD) Randomized to Ruxolitinib (RUX) vs Best Available Therapy (BAT)

Stephanie Lee, Franco Locatelli, Francis A. Ayuk, Tsila Zuckerman, Kentaro Fukushima, Juan Carlos Vallejo Llamas, Joseph Pidala, Nada Hamad, Ivan S. Moiseev, Francesca Bonifazi, Shashikant Apte, Robert Zeiser, Valkal Bhatt, Maanasa Gowda, Jackie Han, Tommaso Stefanelli, Mike W. Zuurman, Takanori Teshima

Blood (2021) 138 (Supplement 1): 3909.

https://doi.org/10.1182/blood-2021-144576

Published: 2021

Journal Articles

AVM0703 Tumor Debulking Enhances Cy/Flu Efficacy

Theresa Deisher, Spencer Sawas, Kathleen Suwito, Colleen Rylatt, Peter A. Jarzyna, Yumna Zahid, Vaishnavi Parthasarathy, Kendra Poulin, Stephanie Lee-Diaz

Blood (2021) 138 (Supplement 1): 4498.

https://doi.org/10.1182/blood-2021-153990

Published: 2021

Journal Articles

AVM0703, a New Treatment Option for Lymphoma Patients

Theresa Deisher, PhD, Margaret Taylor, Arya Ashok, PhD, Peter Jarzyna, PhD, Yumna Zahid, Stephanie Lee-Diaz, Colleen Rylatt, Kendra Poulin, Vaishnavi Parthasarathy

Blood (2019) 134 (Supplement_1): 5308.

https://doi.org/10.1182/blood-2019-128812

Published: 2019

Journal Articles

Dose Modification In MDS Pts Receiving Lenalidomide As a Means To Improve Patient Persistence

B. Douglas Smith, MD, Dalia Mahmoud, MBA, Stephanie Lee, Laura Weber

Blood (2013) 122 (21): 2987.

https://doi.org/10.1182/blood.V122.21.2987.2987

Published: 2013

Journal Articles

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

Marco Mielcarek, Barry E. Storer, Michael Boeckh, Paul A. Carpenter, George B. McDonald, H. Joachim Deeg, Richard A. Nash, Mary E. D. Flowers, Kristine Doney, Stephanie Lee, Kieren A. Marr, Terry Furlong, Rainer Storb, Frederick R. Appelbaum, Paul J. Martin

Blood (2009) 113 (13): 2888–2894.

https://doi.org/10.1182/blood-2008-07-168401

Published: 2009

Includes: Supplemental data

Journal Articles

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

K. Scott Baker, MD, MS, Anna Hassebroek, MPH, Karen Ballen, MD, Carolyn Bigelow, MD, Haydar Frangoul, MD, Cheryl Hardy, PhD, Stephanie Lee, MD,MPH, Galen Switzer, PhD, J. Douglas Rizzo, MD, John P. Klein, PhD, Navneet Majhail, MD,MS, Stella Davies, MB.BS,PhD

Blood (2007) 110 (11): 3064.

https://doi.org/10.1182/blood.V110.11.3064.3064

Published: 2007

Journal Articles

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Meghan Delaney, DO, Beow Yeap, Sc.D, Richard L. Haspel, MD, PhD, Thomas R. Spitzer, MD, Steven L. McAfee, MD, Bimalangshu Dey, MD, PhD, Eyal Attar, MD, Grace Kao, MD, Edwin Alyea, MD, Stephanie Lee, MD, Corey Cutler, MD, Vincent Ho, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Ballen Karen, MD

Blood (2007) 110 (11): 2032.

https://doi.org/10.1182/blood.V110.11.2032.2032

Published: 2007

Journal Articles

Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.

Daniel J. Weisdorf, MD, Stephen Spellman, John Klein, PhD, Michael D. Haagenson, MS, Mary Horowitz, MD, Stephanie Lee, MD, MPH, Claudio Anasetti, MD, Michelle Setterholm, Rebecca Drexler, BS, AAS, Martin Maiers, Roberta King, Dennis Confer, MD

Blood (2007) 110 (11): 45.

https://doi.org/10.1182/blood.V110.11.45.45

Published: 2007

Journal Articles

Impact of Prior Therapy with Imatinib Mesylate on the Outcome of Hematopoietic Cell Transplantation (HCT) for Chronic Myeloiod Leukemia (CML).

Stephanie Lee, MD, Richard Maziarz, MD, Manisha Kukreja, MBBS, MPH, Tao Wang, PhD, Sergio Giralt, MD, Jeffrey Szer, MBBS, Ann Woolfrey, MD, Mukta Arora, MD, MS

Blood (2007) 110 (11): 738.

https://doi.org/10.1182/blood.V110.11.738.738

Published: 2007

Journal Articles

Change of Treatment for Control of Chronic Graft-Versus-Host Disease (cGVHD) as a Time-Dependent Covariate for Nonrelapse Mortality and Survival.

Mary E.D. Flowers, Barry Storer, Paul Carpenter, Afonso Vigorito, Paulo Campregher, Carina Moravec, Hans-Peter Kiem, Fero Matthew, George Georges, Edus Warren, Stephanie Lee, Jean Sanders, Paul Martin

Blood (2007) 110 (11): 833.

https://doi.org/10.1182/blood.V110.11.833.833

Published: 2007

Journal Articles

Differences in Medical Decision Making in Adult and Pediatric Hematopoietic Stem Cell Transplantation (HCT).

Stephanie Lee, Steven Joffe, Andrew Artz, Richard Champlin, Stella Davies, Madan Jagasia, Nancy A. Kernan, Robert J. Soiffer, Mary Eapen

Blood (2006) 108 (11): 74.

https://doi.org/10.1182/blood.V108.11.74.74

Published: 2006

Journal Articles

X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis

Ross L. Levine, Claude Belisle, Martha Wadleigh, David Zahrieh, Stephanie Lee, Pierre Chagnon, D. Gary Gilliland, Lambert Busque

Blood (2006) 107 (10): 4139–4141.

https://doi.org/10.1182/blood-2005-09-3900

Published: 2006

Journal Articles

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Karen K. Ballen, MD, Thomas R. Spitzer, MD, Beow Yeap, ScD, McAfee Steve, MD, Bimalanghsu R. Dey, MD, Eyal Attar, MD, Edwin Alyea, MD, Corey Cutler, MD, Vincent Ho, MD, Stephanie Lee, MD, Robert Soiffer, MD, Joseph H. Antin, MD

Blood (2005) 106 (11): 2048.

https://doi.org/10.1182/blood.V106.11.2048.2048

Published: 2005

Journal Articles

Autologous transplant survivors: out of the woods?

Stephanie Lee

Blood (2005) 105 (11): 4155.

https://doi.org/10.1182/blood-2005-03-1009

Published: 2005

Journal Articles

An update on how to treat chronic GVHD

Mary E. D. Flowers, Stephanie Lee, Georgia Vogelsang

Blood (2003) 102 (6): 2312.

https://doi.org/10.1182/blood-2003-06-2064

Published: 2003

NARROW

Safety and Efficacy of Bezuclastinib (CGT9486), a Novel, Highly Selective, Potent KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (AdvSM): Results from Part 1 of the Phase 2 Apex Trial

Utilization of Natural Language Processing in Venous Thromboembolism Identification

Patient-Reported Outcomes (PROs) Among Patients With Steroid-Refractory or -Dependent Chronic Graft-vs-Host Disease (cGVHD) Randomized to Ruxolitinib (RUX) vs Best Available Therapy (BAT)

AVM0703 Tumor Debulking Enhances Cy/Flu Efficacy

AVM0703, a New Treatment Option for Lymphoma Patients

Dose Modification In MDS Pts Receiving Lenalidomide As a Means To Improve Patient Persistence

Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes

Impact of Ethnicity and Socioeconomic Status on Outcome of Unrelated Donor (URD) Hematopoietic Cell Transplantation (HcT).

HLA Locus-Specific Outcomes in Double Umbilical Cord Blood Reduced Intensity Transplantation (DCBT) in Adults.

Classification of HLA-Matching for Retrospective Analysis of Unrelated Donor Transplantation: Revised Definitions To Predict Survival.

Impact of Prior Therapy with Imatinib Mesylate on the Outcome of Hematopoietic Cell Transplantation (HCT) for Chronic Myeloiod Leukemia (CML).

Change of Treatment for Control of Chronic Graft-Versus-Host Disease (cGVHD) as a Time-Dependent Covariate for Nonrelapse Mortality and Survival.

Differences in Medical Decision Making in Adult and Pediatric Hematopoietic Stem Cell Transplantation (HCT).

X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis

Excellent Disease-Free Survival after Double Cord Blood Transplantation Using a Reduced Intensity Chemotherapy Only Conditioning Regimen in a Diverse Adult Population.

Autologous transplant survivors: out of the woods?

An update on how to treat chronic GVHD

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only